AMRI
Albany Molecular Research Inc.
NasdaqGS
People also watch:ARQLARRYALKSENZNANIK
14.39-0.09 (-0.62%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close14.48
Open14.43
Bid14.42 x 100
Ask14.44 x 500
52wk Range12.45 - 22.48
Day's Range14.17 - 14.45
Volume175,830
Avg Vol (3m)293,155
As of 2:58 PM EDT. NasdaqGS Real Time Price. Market open.
  • Capital Cube2 days ago

    Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US : July 26, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Albany Molecular Research, Inc.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day […] (Read more...) The post Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US : July 26, 2016 appeared first on CapitalCube.

  • Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : July 18, 2016
    Capital Cube10 days ago

    Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : July 18, 2016

    Click here to see latest analysisCapitalcube gives Albany Molecular Research, Inc. a score of 28.Our analysis is based on comparing Albany Molecular Research, Inc. with the following peers – Charles River Laboratories International, Inc., Elite Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Sanofi Sponsored ADR, Aceto Corporation, General Electric Company, Cambrex Corporation, Ligand Pharmaceuticals Incorporated and Array […] (Read more...) The post Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : July 18, 2016 appeared first on CapitalCube.